Machine learning-based QSAR and molecular modeling identify promising PTP1B modulators from Ocimum gratissimum for type 2 diabetes therapy
- PMID: 40549293
- DOI: 10.1007/s11030-025-11255-x
Machine learning-based QSAR and molecular modeling identify promising PTP1B modulators from Ocimum gratissimum for type 2 diabetes therapy
Abstract
Protein tyrosine phosphatase 1B (PTP1B) is a key negative regulator of insulin signaling and a promising therapeutic target for the treatment of type 2 diabetes mellitus. Ocimum gratissimum (African basil) has been traditionally used and reported to enhance insulin sensitivity and promote glucose uptake, however, the molecular basis and active constituents responsible for these biological activities remain poorly characterized. The study focused on bioprospecting O. gratissimum for PTP1B inhibitors through machine learning (ML) and molecular modeling. Predictive ML models were developed using a curated IC50 bioactivity dataset of known PTP1B inhibitors from the ChEMBL database. Among 42 algorithms assessed, the Random Forest Regressor (RFR) exhibited the best performance and identified 49 compounds (pIC50 > 5) out of 156-screened phytochemicals. Molecular docking and 100-ns molecular dynamics (MD) simulations revealed luteolin, isovitexin, and morin as top binders, forming stable hydrogen bonds and hydrophobic interactions with key catalytic residues (CYS215 and ARG221) of PTP1B. Structural dynamics analysis further revealed the stability and conformational flexibility of the flavonoid-PTP1B complexes, while Molecular Mechanics-Poisson-Boltzmann Surface Area (MM-PBSA) binding free energy calculations supported their strong and favorable binding affinities in a dynamic environment. Overall, these findings suggest that luteolin, isovitexin, and morin may serve as potent, non-covalent PTP1B inhibitors, offering mechanistic insight into the insulin-sensitizing potential of O. gratissimum and supporting its ethnopharmacological use in diabetes management. Further experimental validation is recommended to explore and confirm their therapeutic relevance.
Keywords: Ocimum gratissimum; Flavonoids; Insulin sensitization; Machine learning; Protein Tyrosine Phosphatase 1B (PTP1B).
© 2025. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Conflict of interest statement
Declarations. Conflict of interest: No potential conflict of interest is reported by the authors
Similar articles
-
Phenolic-based allosteric inhibition of PTP1B: unlocking new therapeutic potential for metabolic disorders.J Comput Aided Mol Des. 2025 Jun 24;39(1):35. doi: 10.1007/s10822-025-00616-1. J Comput Aided Mol Des. 2025. PMID: 40553177
-
An integrated approach for novel PTP1B inhibitor screening: combining machine learning models, molecular docking, molecular and dynamics simulations.Mol Divers. 2025 Jul 21. doi: 10.1007/s11030-025-11292-6. Online ahead of print. Mol Divers. 2025. PMID: 40690114
-
Exploring Type II Diabetes Inhibitors from Genus Daphne Plant-species: An Integrated Computational Study.Comb Chem High Throughput Screen. 2025;28(8):1413-1442. doi: 10.2174/0113862073262227231005074024. Comb Chem High Throughput Screen. 2025. PMID: 38584562
-
Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.Cochrane Database Syst Rev. 2008 Jul 16;(3):CD001230. doi: 10.1002/14651858.CD001230.pub2. Cochrane Database Syst Rev. 2008. PMID: 18646068
-
Home treatment for mental health problems: a systematic review.Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150. Health Technol Assess. 2001. PMID: 11532236
References
-
- Shittu ST, Lasisi TJ, Shittu SA, Adeyemi A, Adeoye TJ, Alada AA (2021) Ocimum gratissimum enhances insulin sensitivity in male Wistar rats with dexamethasone-induced insulin resistance. J Diabetes Metab Disord 20(2):1257–1267. https://doi.org/10.1007/s40200-021-00850-y - DOI - PubMed - PMC
-
- Ogunyemi OM, Gyebi GA, Saheed A, Paul J, Nwaneri-Chidozie V, Olorundare O, Adebayo J, Koketsu M, Aljarba N, Alkahtani S, Batiha GE-S, Olaiya CO (2022) Inhibition mechanism of alpha-amylase, a diabetes target, by a steroidal pregnane and pregnane glycosides derived from Gongronema latifolium Benth. Front Mol Biosci. https://doi.org/10.3389/fmolb.2022.866719 - DOI - PubMed - PMC
-
- Saklayen MG (2018) The global epidemic of the metabolic syndrome. Curr Hypertens Rep 20(2):12. https://doi.org/10.1007/s11906-018-0812-z - DOI - PubMed - PMC
-
- Goldstein BJ (2002) Protein-tyrosine phosphatases: emerging targets for therapeutic intervention in type 2 diabetes and related states of insulin resistance. J Clin Endocrinol Metab 87(6):2474–2480. https://doi.org/10.1210/jcem.87.6.8641 - DOI - PubMed
-
- Kołodziej-Sobczak D, Sobczak L, Łączkowski KZ (2024) Protein tyrosine phosphatase 1b (ptp1b): a comprehensive review of its role in pathogenesis of human diseases. Int J Mol Sci 2024:25. https://doi.org/10.3390/ijms25137033 - DOI
LinkOut - more resources
Full Text Sources
Miscellaneous